127801-98-3

Basic information

• Product Name: ethyl 2-[2-(benzoylimino)benzo[d]thiazol-3(2H)-yl]acetate
• Synonyms: ethyl 2-[2-(benzoylimino)benzo[d]thiazol-3(2H)-yl]acetate
• CAS NO: 127801-98-3
• Molecular Weight: 340.403
• Mol File: 127801-98-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: ethyl 2-[2-(benzoylimino)benzo[d]thiazol-3(2H)-yl]acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-[2-(benzoylimino)benzo[d]thiazol-3(2H)-yl]acetate(127801-98-3)
• EPA Substance Registry System: ethyl 2-[2-(benzoylimino)benzo[d]thiazol-3(2H)-yl]acetate(127801-98-3)

Safety Data

• Hazardous Substances Data: 127801-98-3(Hazardous Substances Data)

Upstream product

• 5005-14-1 N-(benzo[d]thiazol-2-yl)benzamide 
• 105-36-2 ethyl bromoacetate 
• 98-88-4 benzoyl chloride 
• 136-95-8 2-amino-benzthiazole 

Downstream Products

• 1428621-28-6 2-[2-(benzoylimino)benzo[d]thiazol-3(2H)-yl]acetic acid 

Relevant articles and documents

PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Provided is a phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.